ID   P7E9C7
AC   CVCL_B6D2
DR   Wikidata; Q112129485
RX   Patent=EP0305960A2;
RX   Patent=EP0336405B1;
RX   PubMed=1369271;
RX   PubMed=1369279;
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1810.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50139.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6D1 ! PEA7-1-6D
HI   CVCL_Z044 ! TAW-925
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
RX   Patent=EP0305960A2;
RA   Iwasa S., Ichimori Y., Kuriyama M.;
RT   "A transformant cell line capable of producing a human monoclonal
RT   antibody, hybridoma, their production and use.";
RL   Patent number EP0305960A2, 08-Mar-1989.
//
RX   Patent=EP0336405B1;
RA   Iwasa S., Kuriyama M., Okazaki K., Toyoda Y.;
RT   "Anti-human cancer protein complexes, their production and use.";
RL   Patent number EP0336405B1, 13-Jan-1993.
//
RX   PubMed=1369271; DOI=10.1007/BF00365263;
RA   Kuriyama M., Ichimori Y., Iwasa S., Tsukamoto K.;
RT   "A human-human hybridoma secreting anti-Pseudomonas aeruginosa
RT   exotoxin-A monoclonal antibody with highly potent neutralizing
RT   activity.";
RL   Cytotechnology 3:31-37(1990).
//
RX   PubMed=1369279; DOI=10.1007/BF00148811;
RA   Honda S., Ichimori Y., Iwasa S.;
RT   "A human hybrid hybridoma producing a bispecific monoclonal antibody
RT   that can target tumor cells for attack by Pseudomonas aeruginosa
RT   exotoxin A.";
RL   Cytotechnology 4:59-68(1990).
//